Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.30

-2.8%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (2719)	1/29/2001 8:56:59 PM
From: Biomaven	Read Replies (2) of 52153

george, I've intermittently owned them in the past. My small stake went in my recent year-end tax selling (along with just about everything else I owned that showed even a small loss). The key mystery with their product has been why it also seemed to work in tumors without abnormal p53. This cast doubt on the whole rationale. This post may provide some explanation: Message 14492963 How does Xoma fit in here? I didn't know they were in the manufacturing business. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next